v2.4.1.9

Supplemental data | 3 Months Ended
--- | ---
Mar. 31, 2015
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Supplemental data |
21. | Supplemental data
The following information is presented as supplemental data as required by the indentures governing our senior notes. Condensed Consolidating Statements of Income
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the three months ended March 31, 2015 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Patient service operating revenues |  | $ | 2,271,815 |  |  | $ | 29,654 |  |  | $ | — |  |  | $ | 2,242,161 |
Less: Provision for uncollectible accounts |  |  | (99,164 | ) |  |  | (289 | ) |  |  | — |  |  |  | (98,875 | )
Net patient service operating revenues |  |  | 2,172,651 |  |  |  | 29,365 |  |  |  | — |  |  |  | 2,143,286 |
Capitated revenues |  |  | 850,515 |  |  |  | 386,331 |  |  |  | — |  |  |  | 464,184 |
Other revenues |  |  | 264,799 |  |  |  | 919 |  |  |  | — |  |  |  | 263,880 |
Total net operating revenues |  |  | 3,287,965 |  |  |  | 416,615 |  |  |  | — |  |  |  | 2,871,350 |
Operating expenses |  |  | 3,352,121 |  |  |  | 409,306 |  |  |  | (237 | ) |  |  | 2,943,052 |
Operating (loss) income |  |  | (64,156 | ) |  |  | 7,309 |  |  |  | 237 |  |  |  | (71,702 | )
Debt expense, including refinancing charges |  |  | (97,392 | ) |  |  | (2,464 | ) |  |  | — |  |  |  | (94,928 | )
Other (loss) income |  |  | (533 | ) |  |  | 30 |  |  |  | — |  |  |  | (563 | )
Income tax (benefit) expense |  |  | (85,933 | ) |  |  | 1,489 |  |  |  | 95 |  |  |  | (87,517 | )
Net (loss) income |  |  | (76,148 | ) |  |  | 3,386 |  |  |  | 142 |  |  |  | (79,676 | )
Less: Net income attributable to noncontrolling interests |  |  | (34,469 | ) |  |  | — |  |  |  | — |  |  |  | (34,469 | )
Net (loss) income attributable to DaVita HealthCare Partners Inc. |  | $ | (110,617 | ) |  | $ | 3,386 |  |  | $ | 142 |  |  | $ | (114,145 | )
(1) | After the elimination of the unrestricted subsidiaries and the physician groups
Condensed Consolidating Statements of Comprehensive Income
|  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the three months ended March 31, 2015 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Net (loss) income |  | $ | (76,148 | ) |  | $ | 3,386 |  |  | $ | 142 |  |  | $ | (79,676 | )
Other comprehensive loss |  |  | (22,608 | ) |  |  | — |  |  |  | — |  |  |  | (22,608 | )
Total comprehensive (loss) income |  |  | (98,756 | ) |  |  | 3,386 |  |  |  | 142 |  |  |  | (102,284 | )
Less: comprehensive income attributable to the noncontrolling interests |  |  | (34,469 | ) |  |  | — |  |  |  | — |  |  |  | (34,469 | )
Comprehensive (loss) income attributable to DaVita HealthCare Partners Inc. |  | $ | (133,225 | ) |  | $ | 3,386 |  |  | $ | 142 |  |  | $ | (136,753 | )
(1) | After the elimination of the unrestricted subsidiaries and the physician groups
Condensed Consolidating Balance Sheets
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
As of March 31, 2015 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Cash and cash equivalents |  | $ | 1,011,271 |  |  | $ | 101,416 |  |  | $ | — |  |  | $ | 909,855 |
Accounts receivable, net |  |  | 1,675,182 |  |  |  | 255,659 |  |  |  | — |  |  |  | 1,419,523 |
Other current assets |  |  | 1,614,342 |  |  |  | 9,376 |  |  |  | — |  |  |  | 1,604,966 |
Total current assets |  |  | 4,300,795 |  |  |  | 366,451 |  |  |  | — |  |  |  | 3,934,344 |
Property and equipment, net |  |  | 2,500,596 |  |  |  | 2,212 |  |  |  | — |  |  |  | 2,498,384 |
Amortizable intangibles, net |  |  | 1,904,176 |  |  |  | 7,385 |  |  |  | — |  |  |  | 1,896,791 |
Other long-term assets |  |  | 229,706 |  |  |  | 69,461 |  |  |  | 3,048 |  |  |  | 157,197 |
Goodwill |  |  | 9,431,390 |  |  |  | 15,155 |  |  |  | — |  |  |  | 9,416,235 |
Total assets |  | $ | 18,366,663 |  |  | $ | 460,664 |  |  | $ | 3,048 |  |  | $ | 17,902,951 |
Current liabilities |  | $ | 2,679,516 |  |  | $ | 195,987 |  |  | $ | — |  |  | $ | 2,483,529 |
Payables to parent |  |  | — |  |  |  | 186,830 |  |  |  | 3,048 |  |  |  | (189,878 | )
Long-term debt and other long-term liabilities |  |  | 9,668,041 |  |  |  | 57,470 |  |  |  | — |  |  |  | 9,610,571 |
Noncontrolling interests subject to put provisions |  |  | 848,392 |  |  |  | — |  |  |  | — |  |  |  | 848,392 |
Total DaVita HealthCare Partners Inc. shareholders’ equity |  |  | 4,971,410 |  |  |  | 20,377 |  |  |  | — |  |  |  | 4,951,033 |
Noncontrolling interests not subject to put provisions |  |  | 199,304 |  |  |  | — |  |  |  | — |  |  |  | 199,304 |
Shareholders’ equity |  |  | 5,170,714 |  |  |  | 20,377 |  |  |  | — |  |  |  | 5,150,337 |
Total liabilities and shareholder’s equity |  | $ | 18,366,663 |  |  | $ | 460,664 |  |  | $ | 3,048 |  |  | $ | 17,902,951 |
(1) | After the elimination of the unrestricted subsidiaries and the physician groups
Condensed Consolidating Statements of Cash Flows
|  |  |  |  |  |  |  |  |  |  |  |  |  | Company and |
|  | Consolidated |  |  | Physician |  |  | Unrestricted |  |  | Restricted |
For the three months ended March 31, 2015 |  | Total |  |  | Groups |  |  | Subsidiaries |  |  | Subsidiaries(1) |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (76,148 | ) |  | $ | 3,386 |  |  | $ | 142 |  |  | $ | (79,676 | )
Changes in operating and intercompany assets and liabilities and non-cash items included in net income |  |  | 486,237 |  |  |  | (16,884 | ) |  |  | (142 | ) |  |  | 503,263 |
Net cash provided by (used in) operating activities |  |  | 410,089 |  |  |  | (13,498 | ) |  |  | — |  |  |  | 423,587 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  |  | (121,421 | ) |  |  | 164 |  |  |  | — |  |  |  | (121,585 | )
Acquisitions and divestitures, net |  |  | (40,650 | ) |  |  | — |  |  |  | — |  |  |  | (40,650 | )
Proceeds from discontinued operations |  |  | 2,565 |  |  |  | — |  |  |  | — |  |  |  | 2,565 |
Investments and other items |  |  | (92,781 | ) |  |  | (457 | ) |  |  | — |  |  |  | (92,324 | )
Net cash used in investing activities |  |  | (252,287 | ) |  |  | (293 | ) |  |  | — |  |  |  | (251,994 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt |  |  | (28,439 | ) |  |  | — |  |  |  | — |  |  |  | (28,439 | )
Intercompany |  |  | — |  |  |  | 2,759 |  |  |  | — |  |  |  | (2,759 | )
Other items |  |  | (82,429 | ) |  |  | — |  |  |  | — |  |  |  | (82,429 | )
Net cash used in by financing activities |  |  | (110,868 | ) |  |  | 2,759 |  |  |  | — |  |  |  | (113,627 | )
Effect of exchange rate changes on cash |  |  | (904 | ) |  |  | — |  |  |  | — |  |  |  | (904 | )
Net increase (decrease) in cash |  |  | 46,030 |  |  |  | (11,032 | ) |  |  | — |  |  |  | 57,062 |
Cash and cash equivalents at beginning of period |  |  | 965,241 |  |  |  | 112,448 |  |  |  | — |  |  |  | 852,793 |
Cash and cash equivalents at end of period |  | $ | 1,011,271 |  |  | $ | 101,416 |  |  | $ | — |  |  | $ | 909,855 |
(1) | After the elimination of the unrestricted subsidiaries and the physician groups

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration